Stock 688091 SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Shanghai Yizhong Pharmaceutical Co., Ltd.

Equities

688091

CNE1000050F4

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 28/05/2024 am IST 		5-day change 1st Jan Change
27.2 CNY +0.74% Intraday chart for Shanghai Yizhong Pharmaceutical Co., Ltd. -2.79% -44.75%
30/04 Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises RE
29/04 Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Yizhong Pharmaceutical's Plant Passes Good Manufacturing Practice Inspection of Shanghai's Drug Regulator
MT
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Yizhong Pharma Gets Nod to Trial Lung Cancer Drug in China
MT
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. has completed an IPO in the amount of CNY 1.007745 billion.
CI
Shanghai Yizhong Pharmaceutical Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688091 Stock
  4. News Shanghai Yizhong Pharmaceutical Co., Ltd.
  5. Highlights